| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Fresenius Medical Care AG & Co. KGaA (XETRA: FME)
FME Technical Analysis
5
| As on 28th Nov 2025 FME STOCK Price closed @ 41.25 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 45.58 & Strong Sell for SHORT-TERM with Stoploss of 45.16 we also expect STOCK to react on Following IMPORTANT LEVELS. |
FMESTOCK Price
| Open | 41.25 | Change | Price | % |
| High | 41.37 | 1 Day | 0.11 | 0.27 |
| Low | 41.10 | 1 Week | 1.73 | 4.38 |
| Close | 41.25 | 1 Month | -5.15 | -11.10 |
| Volume | 548511 | 1 Year | -0.23 | -0.55 |
| 52 Week High 53.66 | 52 Week Low 39.52 | ||||
XETRA Germany Most Active Stocks
| LHAR | 2.05 | -20.23% |
| BBVA | 5.00 | -2.72% |
| BBVA | 5.00 | -2.72% |
| BBVA | 5.00 | -2.72% |
| BVBA | 0.02 | -60.00% |
| SNH | 0.16 | 6.67% |
| SNH | 0.16 | 6.67% |
| SNH | 0.16 | 6.67% |
| AMMN | 8500.00 | 1440578.00% |
| PHIA | 31.36 | 1.92% |
XETRA Germany Top Gainers Stocks
XETRA Germany Top Losers Stocks
| FME Daily Charts |
FME Intraday Charts |
Whats New @ Bazaartrend |
FME Free Analysis |
|
|
FME Important Levels Intraday
| RESISTANCE | 41.77 |
| RESISTANCE | 41.60 |
| RESISTANCE | 41.50 |
| RESISTANCE | 41.40 |
| SUPPORT | 41.10 |
| SUPPORT | 41.00 |
| SUPPORT | 40.90 |
| SUPPORT | 40.73 |
FME Forecast November 2025
| 4th UP Forecast | 51.37 |
| 3rd UP Forecast | 48.12 |
| 2nd UP Forecast | 46.12 |
| 1st UP Forecast | 44.11 |
| 1st DOWN Forecast | 38.39 |
| 2nd DOWN Forecast | 36.38 |
| 3rd DOWN Forecast | 34.38 |
| 4th DOWN Forecast | 31.13 |
FME Weekly Forecast
| 4th UP Forecast | 43.93 |
| 3rd UP Forecast | 43.07 |
| 2nd UP Forecast | 42.54 |
| 1st UP Forecast | 42.01 |
| 1st DOWN Forecast | 40.49 |
| 2nd DOWN Forecast | 39.96 |
| 3rd DOWN Forecast | 39.43 |
| 4th DOWN Forecast | 38.57 |
FME Forecast2025
| 4th UP Forecast | 70 |
| 3rd UP Forecast | 60.78 |
| 2nd UP Forecast | 55.08 |
| 1st UP Forecast | 49.38 |
| 1st DOWN Forecast | 33.12 |
| 2nd DOWN Forecast | 27.42 |
| 3rd DOWN Forecast | 21.72 |
| 4th DOWN Forecast | 12.5 |
Fresenius Medical Care AG & Co. KGaA ( XETRA Germany Symbol : FME )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
FME Business Profile
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Address: Else-KrOener Strasse 1, Bad Homburg, Germany, 61352
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service